TNFSF14

Across TCGA pan-cancer cohorts, TNFSF14 Mutation is linked to patient survival in 7 of 34 cancer types, making it a survival-associated TNFSF14 data layer compared with 27 for mass-spec protein.

The strongest signal is observed in brain lower grade glioma (LGG), where higher TNFSF14 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated TNFSF14 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

LGG, STAD, and SKCM are the cancer types where TNFSF14 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	DFS	Median	All	0.302	0.742	<.001	17	view →
STAD	OS	Median	III,IV	0.003	0.633	<.001	15	view →
SKCM	OS	Median	III,IV	0.497	0.716	.018	8	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →
HNSC	OS	Median	All	0.151	0.685	.007	6	view →
COAD	DFS	Median	All	0.255	0.691	.026	5	view →
UCEC	DFS	Median	All	1.000	0.831	.032	4	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

TNFSF14–LGG (DFS)

Open the LGG breakdown →